MedTrace Logo

Measuring Smoking Behavior in People With Schizophrenia and Bipolar Disorder

NCT00382915 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 276

Last updated 2013-05-27

No results posted yet for this study

Summary

This study will evaluate the differences in smoking behavior, nicotine intake, and nicotine boost among people with schizophrenia, bipolar disorder, or no mental illness.

Conditions

Interventions

DEVICE

CReSSmicro handheld topography device

The CReSS micro device represents the state-of-the-art technology for measurements of ambulatory puff topography taken in the smoker's natural environment. Although all topography measurements are limited, at least to some degree, by the artificial act of smoking while using a device, or smoking through a mouthpiece, this small, lightweight and portable device is easy to use outside of the laboratory setting to capture more naturalistic smoking behavior and allows for less intrusion from the research team and research environment.

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • University of Medicine and Dentistry of New Jersey

    lead OTHER

Principal Investigators

  • Jill M. Williams, MD · Rutgers, The State University of New Jersey

  • Kunal K. Gandhi, MBBS, MPH · Rutgers, The State University of New Jersey

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-10-31
Primary Completion
2010-09-30
Completion
2010-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00382915 on ClinicalTrials.gov